Tempus AI, Inc. reported $1.43B of revenue over the trailing twelve months, +50% on the year before. 8 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.43B (to Q2 2026). Net Income: −$254M, trailing twelve months to Q2 2026. Free Cash Flow: −$263M, trailing twelve months to Q2 2026. Op Margin: −20%, trailing twelve months to Q2 2026.

TEMTempus AI, Inc.

HealthcareUSD

$68.46

$42.3752 weeks$103.25

TEM as reported

Tempus AI, Inc. reported $1.43B of revenue over the trailing twelve months, +50% on the year before. 8 reported series are charted on this page, each one as filed.

$1.43B

Revenue, trailing twelve months · to Q2 2026 · +50% against the twelve months before

Net Income: −$254M
Net Income · +27% year on year · trailing twelve months to Q2 2026
Free Cash Flow: −$263M
Free Cash Flow · +278% year on year · trailing twelve months to Q2 2026
Op Margin: −20%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for TEM, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.43B	+50%	Q2 2026
Net Income	−$254M	+27%	Q2 2026
EPS	−$1.45	+383%	Q2 2026
Op Margin	−20%	n/a	Q2 2026
Net Margin	−18%	n/a	Q2 2026
ROE	−55%	n/a	Q2 2026
ROA	−11%	n/a	Q2 2026
Free Cash Flow	−$263M	+278%	Q2 2026